6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8 Maʻemaʻe ≥98.0% (HPLC) Favipiravir Intermediate COVID-19

ʻO ka wehewehe pōkole:

Inoa Kemika: 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile

6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile

CAS: 356783-31-8

ʻAno: Melemele ʻeleʻele a hiki i ka pauka keʻokeʻo

Maʻemaʻe: ≥98.0% (HPLC)

Intermediate o Favipiravir (CAS: 259793-96-9) i ka mālama ʻana i nā maʻi maʻi Influenza a me COVID-19

ʻO ke kūlana kiʻekiʻe, ka hana kālepa

Inquiry: alvin@ruifuchem.com


Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Na Waiwai Kemika:

Inoa Kimia 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile
Nā huaʻōlelo like 6-Fluoro-3-oxo-3,4-Dihydropyrazine-2-Carbonitrile
Helu CAS 356783-31-8
Helu CAT RF-API294
Kūlana Kūʻai Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram
ʻĀpana Molekala C5H2FN3O
Kaumaha Molecular 139.09
Brand Kemika Ruifu

Nā kikoʻī:

'ikamu Nā kikoʻī
Ka nana aku Melemele ʻeleʻele a hiki i ka pauda keʻokeʻo
ʻIkepili IR, HPLC
Māmā (KF) ≤1.0%
Koena ma ka Ignition ≤0.50%
Hoʻokahi haumia ≤1.0%
Huina paumaele ≤2.0%
Nā Metala Kaumaha ≤20ppm
Maemae ≥98.0% (na HPLC)
Kūlana hoʻāʻo Kūlana ʻoihana
Hoʻohana Kūwaena o Favipiravir (CAS 259793-96-9);Antiviral;COVID-19

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

1

FAQ:

Noi:

ʻO 6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile (CAS 356783-31-8) he mea waena o Favipiravir (CAS 259793-96-9).ʻO Favipiravir kahi lāʻau antiviral ākea ākea hou e kuhikuhi ana i ka RNA-dependent RNA polymerase (RdRp).Ua hoʻokumu mua ʻia ʻo Favipiravir i ka hopena o 1990s e kahi hui i kūʻai ʻia ma hope e ka ʻoihana Iapana ʻo Fujifilm ma ke ʻano o kāna hoʻololi ʻana mai ka ʻoihana kiʻi i ka mālama olakino.Ma hope o ka hoʻāʻo ʻia ʻana e kūʻē i ka nui o nā maʻi maʻi, ua ʻae ʻia ka lāʻau lapaʻau ma Iapana i ka makahiki 2014 no ka hoʻohana pilikia ʻana i nā maʻi maʻi maʻi a i ʻole e mālama i nā maʻi maʻi hou.I ka wā o ka puka ʻana o ka coronavirus hou, ua hōʻike ʻia nā hopena o ka Phase I clinical study o ka lāʻau lapaʻau i paʻi ʻia ma Malaki 2020 e loaʻa paha i ka lāʻau lapaʻau ka hopena o ka wikiwiki ʻana i ka maʻi maʻi e hōʻoluʻolu i ka holomua o ka pneumonia coronavirus hou.Hiki ke hoʻohana ʻia ʻo Favipiravir i ka mālama ʻana i nā maʻi me COVID-19 i ʻōlelo ʻia e WHO.Ua hoʻomaʻemaʻe ʻia e ka Drugs Controller General of India (DCGI) no ka hoʻohana ʻana i ka "emergency restricted" ma waena o nā mea maʻi COVID-19.

E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou